METHYLERGONOVINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methylergonovine Maleate, and when can generic versions of Methylergonovine Maleate launch?
Methylergonovine Maleate is a drug marketed by Am Regent, Breckenridge, Amneal Pharms, Chartwell Rx, Granules, Rising, Teva Pharms Usa, and Trupharma. and is included in eight NDAs.
The generic ingredient in METHYLERGONOVINE MALEATE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methylergonovine Maleate
A generic version of METHYLERGONOVINE MALEATE was approved as methylergonovine maleate by AM REGENT on November 24th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYLERGONOVINE MALEATE?
- What are the global sales for METHYLERGONOVINE MALEATE?
- What is Average Wholesale Price for METHYLERGONOVINE MALEATE?
Summary for METHYLERGONOVINE MALEATE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 4 |
| Patent Applications: | 391 |
| Drug Prices: | Drug price information for METHYLERGONOVINE MALEATE |
| DailyMed Link: | METHYLERGONOVINE MALEATE at DailyMed |
Recent Clinical Trials for METHYLERGONOVINE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins University | Early Phase 1 |
| Brigham and Women's Hospital | Phase 4 |
| University of California, San Francisco | Phase 4 |
Pharmacology for METHYLERGONOVINE MALEATE
| Drug Class | Ergot Derivative |
Medical Subject Heading (MeSH) Categories for METHYLERGONOVINE MALEATE
US Patents and Regulatory Information for METHYLERGONOVINE MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | METHYLERGONOVINE MALEATE | methylergonovine maleate | INJECTABLE;INJECTION | 090193-001 | Nov 24, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Usa | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 211455-001 | Mar 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 091577-001 | May 2, 2011 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Trupharma | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 212233-001 | May 1, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Breckenridge | METHYLERGONOVINE MALEATE | methylergonovine maleate | INJECTABLE;INJECTION | 040889-001 | Sep 13, 2010 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Amneal Pharms | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 211483-001 | Sep 10, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
